Physician profile
Christopher Michael Hodnette
NPI 1992140065
$4,093.85
in general payments reported to CMS, 2019-2025
19 companies · $804 in 2025
The $804 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $387 · 2021: $357 · 2022: $503 · 2023: $779 · 2024: $440 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,999 · Education: $25.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,998.61 |
| Education | $25.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,178.52 | 2019-2025 | |
| Janssen Biotech, INC. | $367.73 | 2019-2025 | Stelara, Tremfya |
| Genzyme Corporation | $331.17 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $224.06 | 2019-2024 | Trulance |
| Covidien LP | $123.14 | 2020 | |
| Mallinckrodt Hospital Products INC. | $121.34 | 2023 | Terlivaz |
| Ironwood Pharmaceuticals, INC | $120.68 | 2019-2023 | Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $115.36 | 2019-2020 | |
| Pfizer INC. | $99.94 | 2019 | |
| Ethicon US, LLC | $92.72 | 2021 | |
| Phathom Pharmaceuticals, INC. | $73.28 | 2024 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $66.81 | 2025 | Dupixent |
| Ardelyx, INC. | $56.58 | 2023-2025 | Ibsrela |
| Celltrion USA INC. | $25.12 | 2023 | Yuflyma |
| Shionogi INC | $25.02 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $20.85 | 2019 | |
| Allergan, INC. | $20.58 | 2019 | |
| Shire North American Group INC | $19.20 | 2019 | |
| Kci USA, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hodnette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.